COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,882 Articles (22,568 medRxiv, 8,314 bioRxiv)

Most recent first Previous |  Page 2855: Articles 28541-28550  | Next

Resident physician exposure to novel coronavirus (2019-nCoV, SARS-CoV-2) within New York City during exponential phase of COVID-19 pandemic: Report of the New York City Residency Program Directors COVID-19 Research Group
Breazzano, M. P., Shen, J., Abdelhakim, A. H., Glass, L. R. D., Horowitz, J. D., Xie, S. X., de Moraes, C. G., Chen-Plotkin, A., Chen, R. W. S., New York City Residency Program Directors COVID-19 Research Group
10.1101/2020.04.23.20074310 — Posted: 2020-04-28
Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: A multicenter cohort study
Qi, X., Liu, Y., Fallowfield, J. A., Wang, J., Wang, J., Li, X., Shi, J., Pan, H., Zou, S., Zhang, H., Chen, Z., Li, F., Luo, Y., Mei, M., Liu, H., Wang, Z., Li, J., Yang, H., Xiang, H., Li, X., Liu, T., Zheng, M.-H., Liu, C., Huang, Y., Xu, D., Li, X., Kang, N., He, Q., Gu, Y., Zhang, G., Shao, C., Liu, D., Zhang, L., Li, X., Kawada, N., Jiang, Z., Wang, F., Xiong, B., Takehara, T., Rockey, D. C., COVID-Cirrhosis-CHESS Group
10.1101/2020.04.24.20072611 — Posted: 2020-04-28
Resilient SARS-CoV-2 diagnostics workflows including viral heat inactivation
Lista, M. J., Page, R., Sertkaya, H., Matos, P., Ortiz-Zapater, E., Maguire, T. J. A., Poulton, K., O'Byrne, A., Bouton, C., Dickenson, R. E., Ficarelli, M., Howard, M., Betancor, G., Galao, R. P., Pickering, S., Signell, A. W., Wilson, H., Cliff, P., Patel, A., MacMahon, E., Cunningham, E., Agromayor, M., Martin-Serrano, J., Perucha, E., Mischo, H. E., Shankar-Hari, M., Batra, R., Edgeworth, J., Malim, M., Neil, S., Martinez-Nunez, R. T.
10.1101/2020.04.22.20074351 — Posted: 2020-04-28 Discussion: Offsite
Machine Learning to Predict Mortality and Critical Events in COVID-19 Positive New York City Patients
Vaid, A., Somani, S., Russak, A. J., De Freitas, J. K., Chaudhry, F. F., Paranjpe, I., Johnson, K. W., Lee, S. J., Miotto, R., Zhao, S., Beckmann, N., Naik, N., Arfer, K., Kia, A., Timsina, P., Lala, A., Paranjpe, M., Glowe, P., Golden, E., Danieletto, M., Singh, M., Meyer, D., O'Reilly, P. F., Huckins, L. H., Kovatch, P., Finkelstein, J., Freeman, R. M., Argulian, E., Kasarskis, A., Percha, B., Aberg, J. A., Bagiella, E., Horowitz, C. R., Murphy, B., Nestler, E. J., Schadt, E. E., Cho, J. H., Cordon-Cardo, C., Fuster, V., Charney, D. S., Reich, D. L., Bottinger, E. P., Levin, M. A., Narula, J., Fayad, Z. A., Just, A., Charney, A. W., Nadkarni, G. N., Glicksberg, B. S.
10.1101/2020.04.26.20073411 — Posted: 2020-04-28
Between-centre differences for COVID-19 ICU mortality from early data in England
Qian, Z., Alaa, A. M., van der Schaar, M., Ercole, A.
10.1101/2020.04.19.20070722 — Posted: 2020-04-27
Quality control of low-frequency variants in SARS-CoV-2 genomes
Rayko, M., Komissarov, A.
10.1101/2020.04.26.062422 — Posted: 2020-04-27 Discussion: Onsite
Specific mutations in SARS-CoV2 RNA dependent RNA polymerase and helicase alter protein structure, dynamics and thus function: Effect on viral RNA replication
Begum, F., MUKHERJEE, D., DAS, S., THAGRIKI, D., TRIPATHI, P. P., BANERJEE, A. K., RAY, U.
10.1101/2020.04.26.063024 — Posted: 2020-04-27
Coronavirus, as a source of pandemic pathogens.
Konishi, T.
10.1101/2020.04.26.063032 — Posted: 2020-04-27
Emergence of multiple variants of SARS-CoV-2 with signature structural changes
Bhowmik, D., Pal, S., Lahiri, A., Talukdar, A., Paul, S.
10.1101/2020.04.26.062471 — Posted: 2020-04-27
Role of 1'-Ribose Cyano Substitution for Remdesivir to Effectively Inhibit both Nucleotide Addition and Proofreading in SARS-CoV-2 Viral RNA Replication
Zhang, L., Zhang, D., Yuan, C., Wang, X., Li, Y., Jia, X., Gao, X., Yen, H.-L., Cheung, P., Huang, X.
10.1101/2020.04.27.063859 — Posted: 2020-04-27 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).